FDA clears Sonosite’s hand-held ultrasound

Article

SonoSite of Bothell, WA, this month received premarket clearance for its digital hand-held ultrasound unit. The company announced April 5 that the Food and Drug Administration had cleared the device and that SonoSite would begin its marketing

SonoSite of Bothell, WA, this month received premarket clearance for its digital hand-held ultrasound unit. The company announced April 5 that the Food and Drug Administration had cleared the device and that SonoSite would begin its marketing efforts.

Last May, SonoSite’s prototype device received premarket clearance, which covered 11 clinical applications including obstetrical, gynecological, abdominal, and cardiovascular imaging (SCAN 5/13/98). The new clearance covers such updates to the prototype as increased signal processing ability, and adds transrectal imaging to the device’s list of applications. SonoSite’s scanner will weigh less than 6 pounds and the firm expects to begin selling the units late this year.

The company moved quickly to establish distributor partnerships for the unit, announcing April 7 that it had signed an agreement with Esaote of Genoa, Italy. The agreement gives Esaote distribution rights for the new device in Germany, France, Italy, and the Netherlands.

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Related Content
© 2025 MJH Life Sciences

All rights reserved.